Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin

Journal of Urology

Volumn 164, Issue 2, 2000, Pages 349-351

  D'Hallewin, Marie Ange ^a   De Witte, Peter A ^a   Waelkens, Etienne ^a   Merlevede, Wilfried ^a   Baert, Luc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bladder; Bladder neoplasms; Carcinoma in situ; Fluorescence; Spectrometry

Indexed keywords

BCG VACCINE; HYPERICIN;

ARTICLE; BLADDER CARCINOMA; BLEACHING; CARCINOMA IN SITU; CLINICAL ARTICLE; CYSTOSCOPY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLOMA; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0033942055     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67357-0     Document Type: Article

References (28)

1. Brawn, P. N.: The origin of invasive carcinoma of the bladder. Cancer, 50: 515, 1982
2. Farrow, G. M., Utz, D. C. and Rife, C. C.: Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res, 36: 2495, 1976
3. Koss, L. G., Nakanishi, I. and Freed, S. Z.: Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology, 9: 442, 1977
4. Wolf, H., Melsen, F., Pedersen, S. E. et al: Natural history of carcinoma in situ of the urinary bladder. Scand J Urol Nephrol, suppl., 157: 147, 1994
5. Vicente, J., Chèchile, G. and Algaba, F.: Value of in vivo mucosastaining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol, 13: 15, 1987
6. Baert, L., Berg, R., Van Damme, B. et al: Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urology, 41: 322, 1993
7. Kriegmair, M., Baumgartner, R., Knüchel, R. et al: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol, 155: 105, 1996
8. Jichlinski, P., Wagnieres, G., Forrer, M. et al: Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer. Urol Res, suppl., 25: S3, 1997
9. D'Hallewin, M. A., Vanherzeele, H. and Baert, L.: Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid. Am J Clin Oncol, 21: 223, 1998
10. Lavie, G., Mazur, Y., Lavie, D. et al: The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med Res Rev, 15: 111, 1995
11. Racinet, H.: Formation d'oxygène singulet 1 delta g photosensibilisée par l'hypericine; étude cinétique en milieu micellaire non ionique. J Chim Phys Chim Biol, 85: 971, 1988
12. Giese, A. C.: Hypericism. Photochem Photobiol Rev, 5: 229, 1980
13. Meruelo, D., Lavie, G. and Lavie, D.: Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA, 85: 5230, 1988
14. Okpanyi, S. N., Lidzba, H., Scholl, B. C. et al: Genotoxicity of a standardized Hypericum extract. Drug Res, 40: 851, 1990
15. Linde, K., Ramirez, R., Mulrow, C. D. et al: St John's wort for depression - an overview and meta-analysis of randomized clinical trials. BMJ, 313: 253, 1996
16. Falk, H., Meyer, J. and Oberreiter, M.: A convenient semisynthetic route to hypericin. Monatsch Chem, 124: 339, 1993
17. Henderson, B. W. and Dougherty, T. J.: How does photodynamic therapy work? Photochem Photobiol, 55: 145, 1992
18. Soloway, M. S.: The evaluation and follow-up of patients with Ta, Tcis and T1 bladder cancer. World J Urol, 11: 153, 1993
19. Kiemeney, L. A. L. M., Witjes, J. A., Heijbroek, R. P. et al: Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol, 73: 164, 1994
20. Hadjur, C., Richard, M. J., Parat, M. O. et al: Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5. J Photochem Photobiol B, 27: 139, 1995
21. Hamilton, H. B., Hinton, D. R., Law, R. E. et al: Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application. J Neurosurg, 85: 329, 1996
22. Hadjur, C., Richard, M. J., Parat, M. O. et al: Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem Photobiol, 64: 375, 1996
23. Vandenbogaerde, A. L., Cuveele, F. J., Proot, P. et al: Differential cytotoxic effects induced after photosensitization by hypericin. J Photochem Photobiol B, 38: 136, 1997
24. Ugwu, F., Vandenbogaerde, A. L., Merlevede, W. J. et al: A comparative study on the photocytotoxicity of hypericin on A431 cells using three different assays. Anticancer Res, 18: 1181, 1998
25. Vandenbogaerde, A. L., Delaey, E. M., Vantieghem, A. M. et al: Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem Photobiol, 67: 119, 1998
26. Vandenbogaerde, A. L., Kamuhabwa, A., Delaey, E. et al: Photocytotoxic effect of pseudohypericin versus hypericin. J Photochem Photobiol B, 45: 87, 1998
27. Vandenbogaerde, A. L., Geboes, K. R., Cuveele, J. F. et al: Antitumor activity of photosensitized hypericin on A431 cell xenografts. Anticancer Res, 16: 1619, 1996
28. Vantieghem, A., Assefa, Z., Vandenabeele, P. et al: Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett, 440: 19, 1998